Anders Sode West
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anders Sode West has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Helle Klingenberg Iversen
Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Denmark (H.K.I.).
12 shared publications - Poul Jennum
Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark
8 shared publications Birgit Sander
Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
4 shared publications- Sofie Amalie Simonsen
Department of Neurology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark
4 shared publications Marie Schønsted
Clinical Stroke Research Unit, Department of Neurology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
3 shared publicationsSofie Amalie Simonsen
Department of Neurology, Clinical Stroke Research Unit, Rigshospitalet, Denmark
3 shared publications
Latest Publications
- 2 October 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (5) , 276
Pre-stroke sleep symptoms and neurological outcomes after stroke: an exploratory secondary analysis of two prospective cohorts
- 2 October 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (5) , 276
Pre-stroke sleep symptoms and neurological outcomes after stroke: an exploratory secondary analysis of two prospective cohorts
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1) , 6367510
Fatal Cerebral Air Embolism Following Central Venous Catheter Mishandling in a Stroke Patient: A Case Report
Background: Air embolism is a rare but potentially fatal complication associated with central venous catheter (CVC) use even several days after placement. Although often asymptomatic, large or rapidly introduced volumes of air can result in severe neurologic and cardiovascular compromise. Case Presentation: We report a case of fatal cerebral air embolism in a male stroke patient in his early 60s with a history of diabetes, nephropathy, and peritoneal dialysis. Following ischemic stroke, a CVC was inserted for hemodialysis. Seventeen days after stroke onset, the patient was found unconscious, with seizures and signs of acute neurologic deterioration. The hemodialysis catheter was discovered unplugged and unclamped, suggesting accidental or intentional self‐manipulation. Imaging confirmed a massive air embolism in both arterial and venous cerebral circulations. Despite immediate intervention, the patient remained unconscious and died 5 days later. Autopsy confirmed the diagnosis and excluded cardiac or pulmonary shunts. Conclusion: This case highlights the fatal potential of air embolism following CVC mishandling. Prevention requires meticulous catheter management, staff training, and informing patients about risks.
- 1 January 2026
- Published by Wiley in Case Reports in Critical Care
- Vol. 2026 (1) , 6367510
Open AccessFatal Cerebral Air Embolism Following Central Venous Catheter Mishandling in a Stroke Patient: A Case Report
Background: Air embolism is a rare but potentially fatal complication associated with central venous catheter (CVC) use even several days after placement. Although often asymptomatic, large or rapidly introduced volumes of air can result in severe neurologic and cardiovascular compromise. Case Presentation: We report a case of fatal cerebral air embolism in a male stroke patient in his early 60s with a history of diabetes, nephropathy, and peritoneal dialysis. Following ischemic stroke, a CVC was inserted for hemodialysis. Seventeen days after stroke onset, the patient was found unconscious, with seizures and signs of acute neurologic deterioration. The hemodialysis catheter was discovered unplugged and unclamped, suggesting accidental or intentional self‐manipulation. Imaging confirmed a massive air embolism in both arterial and venous cerebral circulations. Despite immediate intervention, the patient remained unconscious and died 5 days later. Autopsy confirmed the diagnosis and excluded cardiac or pulmonary shunts. Conclusion: This case highlights the fatal potential of air embolism following CVC mishandling. Prevention requires meticulous catheter management, staff training, and informing patients about risks.
- Open Access
- 18 May 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108345
Sleepiness, fatigue, and obstructive sleep apnea in stroke patients
- 18 May 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (8) , 108345
Open AccessSleepiness, fatigue, and obstructive sleep apnea in stroke patients
- Open Access
- 17 December 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108204
Stroke recurrence and all-cause mortality in CPAP-treated sleep-disordered-breathing patients
- 17 December 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (2) , 108204
Open AccessStroke recurrence and all-cause mortality in CPAP-treated sleep-disordered-breathing patients
- Open Access
- 1 August 2024
- Published by Ubiquity Press, Ltd. in Journal of Circadian Rhythms
- Vol. 22 (1) , 3
Circadian Temperature in Moderate to Severe Acute Stroke Patients
Stroke patients often present circadian disruption due to multiple causes e.g., primary disease, comorbidities, medication, immobilization, reduced daylight entrainment and sleep disturbances. To investigate the circadian rhythm of temperature in forehead skin in patients with moderate to severe stroke admitted for rehabilitation. A physiologic study in form of a secondary analysis of a former randomized study. In total 27 patients with moderate to severe stroke were included between May 1st 2014, and June 1st 2015. Circadian temperature was collected approx. seven days after admission at the acute stroke unit by a skin surface temperature probe as part of a Polysomnography (PSG) measurement. Temperature variations show no circadian rhythm (Type 3 tests of fixed effects by SAS, p = 0.1610). The median temperature variance did fluctuate, but not significantly, and the small changes in circadian temperature variance did not follow the normal temperature variance. Patients with moderate to severe stroke show an abrogated circadian rhythm of temperature. There is an unmet need to understand the mechanisms for this, significance for stroke outcome and treatment.
- 1 August 2024
- Published by Ubiquity Press, Ltd. in Journal of Circadian Rhythms
- Vol. 22 (1) , 3
Open AccessCircadian Temperature in Moderate to Severe Acute Stroke Patients
Stroke patients often present circadian disruption due to multiple causes e.g., primary disease, comorbidities, medication, immobilization, reduced daylight entrainment and sleep disturbances. To investigate the circadian rhythm of temperature in forehead skin in patients with moderate to severe stroke admitted for rehabilitation. A physiologic study in form of a secondary analysis of a former randomized study. In total 27 patients with moderate to severe stroke were included between May 1st 2014, and June 1st 2015. Circadian temperature was collected approx. seven days after admission at the acute stroke unit by a skin surface temperature probe as part of a Polysomnography (PSG) measurement. Temperature variations show no circadian rhythm (Type 3 tests of fixed effects by SAS, p = 0.1610). The median temperature variance did fluctuate, but not significantly, and the small changes in circadian temperature variance did not follow the normal temperature variance. Patients with moderate to severe stroke show an abrogated circadian rhythm of temperature. There is an unmet need to understand the mechanisms for this, significance for stroke outcome and treatment.
- 25 April 2023
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 449, 120664
Pleocytosis in cerebrospinal fluid attributed to ischemic stroke: A review of the literature
- 25 April 2023
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 449, 120664
Pleocytosis in cerebrospinal fluid attributed to ischemic stroke: A review of the literature
- Open Access
- 19 March 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (3) , 496
Is the TOAST Classification Suitable for Use in Personalized Medicine in Ischemic Stroke?
Pathophysiologic classification of ischemic stroke is essential to a personalized approach to stroke treatment. The Trial of Org 101072 in Acute Stroke Treatment (TOAST) classification is the most frequently used tool to classify index ischemic strokes. We aimed to assess presence of small and large vessel disease markers across the TOAST groups. In an observational study, 99 ischemic stroke patients were consecutively included and classified according to TOAST. The assessment was supplemented with cerebral small vessel disease (SVD) score, based on Magnetic Resonance Imaging (MRI), and tests for carotid atherosclerosis, ankle–brachial index (ABI), estimated glomerular filtration rate (eGFR), and peripheral reactive hyperemia index (RHI). Markers of small and large vessel disease were present in all TOAST groups. Carotid stenosis and atrial fibrillation were associated with their respective TOAST groups (p = 0.023 and p < 0.001, respectively). We found no association between the SVD score and the small vessel occlusion TOAST group (p = 0.59), and carotid atherosclerosis (p = 0.35), RHI (p = 0.39), ABI (p = 0.20), and eGFR (p = 0.79) were not associated with TOAST groups. The TOAST classification does not provide differential information on the pathophysiologies of the ischemic stroke. An operational classification that contains quantification of each vascular pathophysiology in the individual patient is pivotal for future research and development of personalized medicine.
- 19 March 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (3) , 496
Open AccessIs the TOAST Classification Suitable for Use in Personalized Medicine in Ischemic Stroke?
Pathophysiologic classification of ischemic stroke is essential to a personalized approach to stroke treatment. The Trial of Org 101072 in Acute Stroke Treatment (TOAST) classification is the most frequently used tool to classify index ischemic strokes. We aimed to assess presence of small and large vessel disease markers across the TOAST groups. In an observational study, 99 ischemic stroke patients were consecutively included and classified according to TOAST. The assessment was supplemented with cerebral small vessel disease (SVD) score, based on Magnetic Resonance Imaging (MRI), and tests for carotid atherosclerosis, ankle–brachial index (ABI), estimated glomerular filtration rate (eGFR), and peripheral reactive hyperemia index (RHI). Markers of small and large vessel disease were present in all TOAST groups. Carotid stenosis and atrial fibrillation were associated with their respective TOAST groups (p = 0.023 and p < 0.001, respectively). We found no association between the SVD score and the small vessel occlusion TOAST group (p = 0.59), and carotid atherosclerosis (p = 0.35), RHI (p = 0.39), ABI (p = 0.20), and eGFR (p = 0.79) were not associated with TOAST groups. The TOAST classification does not provide differential information on the pathophysiologies of the ischemic stroke. An operational classification that contains quantification of each vascular pathophysiology in the individual patient is pivotal for future research and development of personalized medicine.
- Open Access
- 5 March 2022
- Published by Taylor & Francis in Brain Injury
- Vol. 36 (6) , 792-799
Quantification of Tau-A in serum after brain injury: a comparison of two analytical platforms, ELISA and electrochemiluminescence immunoassay
Previous studies have indicated the utility of the ADAM10-generated fragment of tau, Tau-A, as marker of neuronal damage. However, the sensitivity of the ELISA-based system was limited. We utilized the extensive dynamic range of electrochemiluminescence compared to colorimetric assessment to improve the sensitivity of the Tau-A assay and investigate Tau-A levels after brain injury. We converted the Tau-A competitive ELISA to a competitive electrochemiluminescence-based immunoassay, Tau-A ECLIA, and compared the methods by measuring serum samples in a TBI (n = 40) and a stroke cohort (n = 64). The Tau-A ECLIA was technically robust. Only 1% of the samples was below the detection limit in the ECLIA compared to 10.6% in the ELISA . Tau-A measured in both assays could discriminate between patients with a TBI and non-trauma controls (ELISA: p = 0.0005, ECLIA: p = 0.0002). The increased dynamic range of the Tau-A ECLIA also allowed discrimination between healthy controls from patients with hemorrhagic (p = 0.0172) and severe ischemic stroke (p = 0.0118) respectively, as well as patients with mild ischemic stroke from severe (p = 0.0445). The Tau-A ECLIA was characterized by dynamic range compared to the ELISA, which facilitated a better separation between the patient groups. Tau-A warrants further investigation as a neuronal injury associated marker.
- 5 March 2022
- Published by Taylor & Francis in Brain Injury
- Vol. 36 (6) , 792-799
Open AccessQuantification of Tau-A in serum after brain injury: a comparison of two analytical platforms, ELISA and electrochemiluminescence immunoassay
Previous studies have indicated the utility of the ADAM10-generated fragment of tau, Tau-A, as marker of neuronal damage. However, the sensitivity of the ELISA-based system was limited. We utilized the extensive dynamic range of electrochemiluminescence compared to colorimetric assessment to improve the sensitivity of the Tau-A assay and investigate Tau-A levels after brain injury. We converted the Tau-A competitive ELISA to a competitive electrochemiluminescence-based immunoassay, Tau-A ECLIA, and compared the methods by measuring serum samples in a TBI (n = 40) and a stroke cohort (n = 64). The Tau-A ECLIA was technically robust. Only 1% of the samples was below the detection limit in the ECLIA compared to 10.6% in the ELISA . Tau-A measured in both assays could discriminate between patients with a TBI and non-trauma controls (ELISA: p = 0.0005, ECLIA: p = 0.0002). The increased dynamic range of the Tau-A ECLIA also allowed discrimination between healthy controls from patients with hemorrhagic (p = 0.0172) and severe ischemic stroke (p = 0.0118) respectively, as well as patients with mild ischemic stroke from severe (p = 0.0445). The Tau-A ECLIA was characterized by dynamic range compared to the ELISA, which facilitated a better separation between the patient groups. Tau-A warrants further investigation as a neuronal injury associated marker.
- 4 January 2022
- Published by Taylor & Francis in Chronobiology International
- Vol. 39 (4) , 476-492
Melatonin profile in healthy, elderly subjects - A systematic literature review
Melatonin plays an important role in regulation and maintaining of the circadian rhythm. In the elderly population, an array of disturbances of circadian rhythm and sleep can be observed; however the current knowledge within the group of healthy, elderly is scarce. This systematic literature review of studies on the melatonin profile measured in the blood of healthy, elderly individuals included 519 studies, found in the primary search on PubMed. After reviewing the title and abstract, 47 studies were found eligible for full text review. The inclusion criteria were defined as follows: healthy, elderly individuals, with a mean or average age over 65 years and analysis done in blood or plasma. In addition to the primary search, three studies were directly identified by the reference lists of already included studies. A final total of 23 studies were included in the systematic literature review. In reviewing the literature, a clear circadian melatonin profile with a nocturnal peak at 3 am and lower daytime levels was observed in the healthy, elderly population. In elderly over 75 years of age, the nocturnal level of melatonin may be lower; however, the circadian rhythmicity is maintained. In the comparison of elderly, independently living individuals and individuals living in care facilities, the latter group had lower levels of nocturnal melatonin peak as well as higher daytime levels; however one can wonder if elderly in care facilities are healthy. The 23 included studies in the systematic literature review had varying primary objectives and generally the term “healthy” within this population group proves difficult to clearly define. As a result of this, an obvious interstudy variability existed, which is a limitation of this systematic literature review. However, the graphs depicted represent the best possible estimation of the melatonin profile in a healthy, elderly population. Future research in the melatonin profile within this population should focus on clearly defined healthy elderly to ensure a valid normal material in this age group.
- 4 January 2022
- Published by Taylor & Francis in Chronobiology International
- Vol. 39 (4) , 476-492
Melatonin profile in healthy, elderly subjects - A systematic literature review
Melatonin plays an important role in regulation and maintaining of the circadian rhythm. In the elderly population, an array of disturbances of circadian rhythm and sleep can be observed; however the current knowledge within the group of healthy, elderly is scarce. This systematic literature review of studies on the melatonin profile measured in the blood of healthy, elderly individuals included 519 studies, found in the primary search on PubMed. After reviewing the title and abstract, 47 studies were found eligible for full text review. The inclusion criteria were defined as follows: healthy, elderly individuals, with a mean or average age over 65 years and analysis done in blood or plasma. In addition to the primary search, three studies were directly identified by the reference lists of already included studies. A final total of 23 studies were included in the systematic literature review. In reviewing the literature, a clear circadian melatonin profile with a nocturnal peak at 3 am and lower daytime levels was observed in the healthy, elderly population. In elderly over 75 years of age, the nocturnal level of melatonin may be lower; however, the circadian rhythmicity is maintained. In the comparison of elderly, independently living individuals and individuals living in care facilities, the latter group had lower levels of nocturnal melatonin peak as well as higher daytime levels; however one can wonder if elderly in care facilities are healthy. The 23 included studies in the systematic literature review had varying primary objectives and generally the term “healthy” within this population group proves difficult to clearly define. As a result of this, an obvious interstudy variability existed, which is a limitation of this systematic literature review. However, the graphs depicted represent the best possible estimation of the melatonin profile in a healthy, elderly population. Future research in the melatonin profile within this population should focus on clearly defined healthy elderly to ensure a valid normal material in this age group.
- 3 November 2021
- Published by Taylor & Francis in Chronobiology International
- Vol. 39 (2) , 299-310
Clinical outcomes of light therapy in hospitalized patients – A systematic review
Light therapy and the effects on biological function have been known and investigated for decades. Light therapy is used to compensate for the lack of exposure to sunlight, which is thought to be linked to major depressive disorder with seasonal patterns. It is applied as sessions with bright light mimicking natural sunlight. Lack of bright light during daytime is not the only factor to maintain the circadian rhythm, also lack of exposure to bright light at night is important. A new modality called naturalistic light shows promise, mimicking daylight by dynamically changing intensity and wavelengths throughout the day. Evidence of clinical effects, besides bright light effects on depression, is still limited, especially in hospital populations, and present review aims to extract results of the effect of any optical light intervention on hospitalized patients. Through database search, 29 trials were included, of which 8 trials used a variation of naturalistic light. Trials were heterogeneous regarding designs, populations, interventions, methods and outcomes. In 14 out of 17 studies investigating sleep duration, quality and circadian alignment, along with decreased fatigue and improved mood in daytime, light therapy had a significant effect. Circadian rhythm and rhythmicity were affected as well. The effect on mood and cognition was inconsistent across studies. Trials showed more significant outcomes when conducted in non-intensive care units and with duration >5 days. Lux was reported in and compared across 24 studies and did not appear to be correlated to outcome, rather the distribution of wavelengths should be considered when conducting trials in the future. Of the 8 trials investigating naturalistic light, 4 trials had significant outcomes and 3 had adverse outcomes compared to one in the standard light regime. The overall effect of light therapy is beneficial, but evidence for the effect of naturalistic light is still insufficient to be recommended before other modalities. Future research in this area should be conducted in facilities where naturalistic light is installed, with a focus on the spectral distribution.
- 3 November 2021
- Published by Taylor & Francis in Chronobiology International
- Vol. 39 (2) , 299-310
Clinical outcomes of light therapy in hospitalized patients – A systematic review
Light therapy and the effects on biological function have been known and investigated for decades. Light therapy is used to compensate for the lack of exposure to sunlight, which is thought to be linked to major depressive disorder with seasonal patterns. It is applied as sessions with bright light mimicking natural sunlight. Lack of bright light during daytime is not the only factor to maintain the circadian rhythm, also lack of exposure to bright light at night is important. A new modality called naturalistic light shows promise, mimicking daylight by dynamically changing intensity and wavelengths throughout the day. Evidence of clinical effects, besides bright light effects on depression, is still limited, especially in hospital populations, and present review aims to extract results of the effect of any optical light intervention on hospitalized patients. Through database search, 29 trials were included, of which 8 trials used a variation of naturalistic light. Trials were heterogeneous regarding designs, populations, interventions, methods and outcomes. In 14 out of 17 studies investigating sleep duration, quality and circadian alignment, along with decreased fatigue and improved mood in daytime, light therapy had a significant effect. Circadian rhythm and rhythmicity were affected as well. The effect on mood and cognition was inconsistent across studies. Trials showed more significant outcomes when conducted in non-intensive care units and with duration >5 days. Lux was reported in and compared across 24 studies and did not appear to be correlated to outcome, rather the distribution of wavelengths should be considered when conducting trials in the future. Of the 8 trials investigating naturalistic light, 4 trials had significant outcomes and 3 had adverse outcomes compared to one in the standard light regime. The overall effect of light therapy is beneficial, but evidence for the effect of naturalistic light is still insufficient to be recommended before other modalities. Future research in this area should be conducted in facilities where naturalistic light is installed, with a focus on the spectral distribution.